Table 1

Baseline Demographic and Lesion Characteristics

Lutonix DCB
(n = 49)
Uncoated Balloon
(n = 52)
p Value
Age, yrs67 ± 870 ± 100.08
Male34 (69)30 (58)0.22
Smoking, current15 (31)20 (39)0.69
Type 2 diabetes mellitus22 (45)26 (50)0.61
Hypertension47 (96)45 (87)0.10
Dyslipidemia29 (59)36 (69)0.29
Previous coronary artery disease19 (39)23 (44)0.58
Peripheral vascular parameters
 History of peripheral vascular disease32 (65)28 (54)0.24
 Baseline Rutherford category0.80
 211 (22)11 (21)
 335 (72)37 (71)
 41 (2)2 (4)
 52 (4)2 (4)
 Ankle-brachial index (treated side)0.69 ± 0.230.60 ± 0.360.18
Baseline lesion characteristics
 Target lesion location0.62
 Superficial femoral artery45 (92)49 (94)
 Popliteal artery4 (8)3 (6)
Reference vessel diameter, mm4.1 ± 0.64.2 ± 0.70.44
In-segment diameter stenosis, %85.2 ± 16.585.3 ± 17.40.98
Lesion length, mm80.8 ± 37.080.2 ± 37.80.89
De novo lesions44 (90)46 (88)0.83
Total occlusions20 (41)22 (42)0.88

Values are mean ± SD or n (%).

DCB = drug-coated balloon.

  • Quantitative vascular angiography measurements.